Cargando…

DDEL-03. The use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with CNS tumors and hydrocephalus.

INTRODUCTION: Current chemotherapy protocols for treatment of embryonal brain tumors in infants recommend administration of intrathecal chemotherapy either by a lumbar tap or via an Ommaya reservoir. Children with concurrent hydrocephalus and shunts may have sub-therapeutic levels of chemotherapy in...

Descripción completa

Detalles Bibliográficos
Autores principales: Dvir, Rina, Rosenberg, Tom, Elhasid, Ronit, Levin, Dror, Constantini, Shlomi, Roth, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164974/
http://dx.doi.org/10.1093/neuonc/noac079.124
_version_ 1784720275339739136
author Dvir, Rina
Rosenberg, Tom
Elhasid, Ronit
Levin, Dror
Constantini, Shlomi
Roth, Jonathan
author_facet Dvir, Rina
Rosenberg, Tom
Elhasid, Ronit
Levin, Dror
Constantini, Shlomi
Roth, Jonathan
author_sort Dvir, Rina
collection PubMed
description INTRODUCTION: Current chemotherapy protocols for treatment of embryonal brain tumors in infants recommend administration of intrathecal chemotherapy either by a lumbar tap or via an Ommaya reservoir. Children with concurrent hydrocephalus and shunts may have sub-therapeutic levels of chemotherapy in the CSF due to constant CSF drainage to extra-CNS compartments. We present our experience in delivery of chemotherapy to young children via programmable valves. RESULTS: A retrospective analysis of infants with CNS malignancies and hydrocephalus treated with a shunt and a programmable valve (CERTAS™ Plus Programmable Valves - Integra Life Sciences) was conducted. Five infants 1.1-3 years of age (mean 2) were included. Pathologies included atypical teratoid rhabdoid tumor (ATRT N=2), medulloblastoma (N=2), and metastatic rhabdomyosarcoma(N=1). Intrathecal injections were conducted in an outpatient setting unless hospitalization was required for other reasons. Only one child required sedation due to noncompliance. A total of 61 chemotherapeutic administrations were performed directly through the valve while set on an extremely high opening pressure for several hours( 35 with hydrocortisone and cytarabine, 26 with topotecan). There were no infections, leaks or major complications. One child required a wound revision due to exposure of the proximal catheter related to extremely thin skin, one child developed somnolence and fever which were not related to a shunt malfunction or infection, and one child had clinical and radiological shunt over-drainage solved by increasing of valve settings. CONCLUSIONS: Programmable ventriculoperitoneal valves appear to a safe method for delivery of chemotherapy in infants with malignant CNS tumors .This technique may potentially have an added value for children with concurrent shunts, and may also obviate the need for an additional ventricular access device .
format Online
Article
Text
id pubmed-9164974
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91649742022-06-05 DDEL-03. The use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with CNS tumors and hydrocephalus. Dvir, Rina Rosenberg, Tom Elhasid, Ronit Levin, Dror Constantini, Shlomi Roth, Jonathan Neuro Oncol Drug Delivery/Pharmacokinetics INTRODUCTION: Current chemotherapy protocols for treatment of embryonal brain tumors in infants recommend administration of intrathecal chemotherapy either by a lumbar tap or via an Ommaya reservoir. Children with concurrent hydrocephalus and shunts may have sub-therapeutic levels of chemotherapy in the CSF due to constant CSF drainage to extra-CNS compartments. We present our experience in delivery of chemotherapy to young children via programmable valves. RESULTS: A retrospective analysis of infants with CNS malignancies and hydrocephalus treated with a shunt and a programmable valve (CERTAS™ Plus Programmable Valves - Integra Life Sciences) was conducted. Five infants 1.1-3 years of age (mean 2) were included. Pathologies included atypical teratoid rhabdoid tumor (ATRT N=2), medulloblastoma (N=2), and metastatic rhabdomyosarcoma(N=1). Intrathecal injections were conducted in an outpatient setting unless hospitalization was required for other reasons. Only one child required sedation due to noncompliance. A total of 61 chemotherapeutic administrations were performed directly through the valve while set on an extremely high opening pressure for several hours( 35 with hydrocortisone and cytarabine, 26 with topotecan). There were no infections, leaks or major complications. One child required a wound revision due to exposure of the proximal catheter related to extremely thin skin, one child developed somnolence and fever which were not related to a shunt malfunction or infection, and one child had clinical and radiological shunt over-drainage solved by increasing of valve settings. CONCLUSIONS: Programmable ventriculoperitoneal valves appear to a safe method for delivery of chemotherapy in infants with malignant CNS tumors .This technique may potentially have an added value for children with concurrent shunts, and may also obviate the need for an additional ventricular access device . Oxford University Press 2022-06-03 /pmc/articles/PMC9164974/ http://dx.doi.org/10.1093/neuonc/noac079.124 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Drug Delivery/Pharmacokinetics
Dvir, Rina
Rosenberg, Tom
Elhasid, Ronit
Levin, Dror
Constantini, Shlomi
Roth, Jonathan
DDEL-03. The use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with CNS tumors and hydrocephalus.
title DDEL-03. The use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with CNS tumors and hydrocephalus.
title_full DDEL-03. The use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with CNS tumors and hydrocephalus.
title_fullStr DDEL-03. The use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with CNS tumors and hydrocephalus.
title_full_unstemmed DDEL-03. The use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with CNS tumors and hydrocephalus.
title_short DDEL-03. The use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with CNS tumors and hydrocephalus.
title_sort ddel-03. the use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with cns tumors and hydrocephalus.
topic Drug Delivery/Pharmacokinetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164974/
http://dx.doi.org/10.1093/neuonc/noac079.124
work_keys_str_mv AT dvirrina ddel03theuseofprogrammablevalvesasavehicleforintrathecalchemotherapydeliveryininfantswithcnstumorsandhydrocephalus
AT rosenbergtom ddel03theuseofprogrammablevalvesasavehicleforintrathecalchemotherapydeliveryininfantswithcnstumorsandhydrocephalus
AT elhasidronit ddel03theuseofprogrammablevalvesasavehicleforintrathecalchemotherapydeliveryininfantswithcnstumorsandhydrocephalus
AT levindror ddel03theuseofprogrammablevalvesasavehicleforintrathecalchemotherapydeliveryininfantswithcnstumorsandhydrocephalus
AT constantinishlomi ddel03theuseofprogrammablevalvesasavehicleforintrathecalchemotherapydeliveryininfantswithcnstumorsandhydrocephalus
AT rothjonathan ddel03theuseofprogrammablevalvesasavehicleforintrathecalchemotherapydeliveryininfantswithcnstumorsandhydrocephalus